Handman E, McConville M J, Goding J W
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3050, Australia.
Department of Pathology and Immunology, Monash University Medical School, Alfred Hospital, Prahran, Victoria 3181, Australia.
Immunol Today. 1987;8(6):181-5. doi: 10.1016/0167-5699(87)90036-3.
Vaccination is one of the most cost-effective means of controlling and eradicating infectious disease but at present there is no vaccine against any human parasitic disease. Developments in gene cloning have focused attention on protein antigen vaccines and have opened the way for their large-scale production. There is, however, another class of non-clonable, biologically important molecules, the complex carbohydrates. In this review Emanuela Handman and her colleagues examine the structure and function of carbohydrate antigens of Leishmania, and their possible role in the search for a vaccine against this organism.
接种疫苗是控制和根除传染病最具成本效益的手段之一,但目前尚无针对任何人类寄生虫病的疫苗。基因克隆技术的发展使人们将注意力集中在蛋白质抗原疫苗上,并为其大规模生产开辟了道路。然而,还有另一类不可克隆的、具有生物学重要性的分子,即复合碳水化合物。在这篇综述中,伊曼纽拉·汉德曼及其同事研究了利什曼原虫碳水化合物抗原的结构和功能,以及它们在寻找针对该生物体的疫苗中可能发挥的作用。